Osteoporosis Foundation of New Mexico Santa Fe Bone

🦴 Santa Fe Bone Symposium 2025

Advanced Osteoporosis & Metabolic Bone Disease Course

---

📌 Overview

The Osteoporosis Foundation of New Mexico Santa Fe Bone Symposium 2025 is a high-level clinical program focused on osteoporosis, metabolic bone disorders, and complex patient management.

Organized by the Osteoporosis Foundation of New Mexico, this symposium delivers evidence-based updates, rare case discussions, and advanced diagnostic strategies for clinicians managing bone health.

---

📦 Course Details

• 🎥 16 Videos (MP4)
• 🎧 16 Audios (MP3)
• 💬 16 Subtitles (VTT)
• 📄 16 PDFs (Slides)
• 💾 Size: 13.43 GB
• 📅 Year: 2025

---

🎯 Target Audience

• Endocrinologists
• Rheumatologists
• Primary care physicians
• Internists
• Bone health specialists

---

🧠 What You’ll Learn

---

🦴 Advanced Osteoporosis Diagnosis

• Interpretation of DXA scans
• Use of Trabecular Bone Score (TBS)
• Identifying diagnostic pitfalls

---

🧬 Rare & Genetic Bone Disorders

• WNT1 mutation–related osteoporosis
• Vitamin D–dependent rickets
• Emerging diagnostic approaches

---

⚠️ Complex Clinical Scenarios

• Atypical femur fractures
• Complications during denosumab therapy
• Perioprosthetic fractures

---

👨‍⚕️ Special Populations

• Osteoporosis in men
• Premenopausal osteoporosis
• Patients with anorexia nervosa
• Rural healthcare challenges

---

💊 Treatment & Therapeutics

• Parathyroid hormone (PTH) analogs
• Anabolic vs antiresorptive therapies
• Safety and adverse event management

---

🧪 Clinical Decision-Making

• Bone biopsy insights
• Histomorphometry applications
• Personalized treatment strategies

---

📚 Topics Included

• 50 years of osteoporosis evolution
• Genetic osteoporosis (WNT1 mutation)
• Hypercalcemia and PTHrP evaluation
• Immune therapy–related endocrine complications
• Osteoporosis in men
• Atypical fracture management
• Rare bone disease updates
• Adverse effects of therapy
• DXA and TBS interpretation
• Perioprosthetic fracture management

---

🎓 Learning Objectives

After completing this course, you will be able to:

• Interpret advanced bone density diagnostics (DXA & TBS)
• Diagnose and manage rare bone diseases
• Treat complex osteoporosis cases and complications
• Apply evidence-based therapeutic strategies
• Optimize care for special populations

---

⭐ Why This Course Stands Out

• ✔️ Strong focus on complex and rare cases
• ✔️ Combines diagnostics + treatment + real-world scenarios
• ✔️ Covers cutting-edge therapies and controversies
• ✔️ Highly relevant for daily clinical practice
• ✔️ Multidisciplinary approach

---

🚀 Clinical Value

This course is ideal for clinicians who want to:

• Improve accuracy in osteoporosis diagnosis
• Manage challenging fracture cases confidently
• Stay updated on new therapies and guidelines
• Deliver personalized bone health care

4. Topics

1. 01 Lessons from 50 Years of Osteoporosis – Evolving Definitions, DEXA, and Treatment Strategies

2. 02 Early-Onset Osteoporosis With WNT1 Mutation – Genetic Diagnosis and Management

3. 03 PTHrP in Non-Malignant Hypercalcemia – What PTHrP Level Warrants Malignancy Workup

4. 04 Vitamin D Dependent Rickets Type 1A – Severe Complications from Delayed Treatment in a Pediatric Case

5. 05 Immune Checkpoint Inhibitors – Rare Case of Hypoparathyroidism in Metastatic Endometrial Cancer

6. 06 Osteoporosis in Men – Addressing Underdiagnosis, Targeted Screening, and Treatment Approaches

7. 07 Atypical Fractures During Denosumab Therapy in Osteoporosis – Management Dilemmas

8. 08 Osteoporosis With Atypical Femur Fracture – Navigating Postfracture Management Dilemmas

9. 09 Bone Health in Rural Patients – Navigating Therapy Choices for Osteoporosis and Paget Disease

10. 10 Rare Bone Diseases – 2025 Updates in Diagnosis and Emerging Therapeutics

11. 11 Adverse Events With Osteoporosis Therapies – Practical Strategies for Side Effect Management

12. 12 Anorexia Nervosa and Premenopausal Osteoporosis – Diagnostic and Management Challenges

13. 13 Osteoporosis Treatment Insights – Lessons from Bone Biopsy and Histomorphometry

14. 14 Parathyroid Hormone Analogs in Osteoporosis – Efficacy, Anabolic Window, and Safety Considerations

15. 15 Osteoporosis Assessment – Navigating DXA Quality, TBS, and Clinical Pitfalls

16. 16 Perioprosthetic Fractures in Osteoporotic Patients – Diagnosis, Management, and Prevention